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Prostaglandins are C20 fatty acid metabolites with diverse biological functions. In mammalian cells, prostaglandins
are produced from arachidonic acid (AA) via cyclooxygenases (COX1 and COX2). Although fungi do not possess
cyclooxygenase homologues, several pathogenic species are able to produce prostaglandins from host-derived
arachidonic acid. In this study, we characterized the prostaglandin proﬁle of the emerging human pathogen Candida
parapsilosis with HPLC-MS and compared it to that of C. albicans. We found that both species synthesized
prostaglandins (mainly PGD2 and PGE2) from exogenous AA. Furthermore, as OLE2 has been associated with
prostaglandin synthesis in C. albicans, we generated homozygous OLE2 deletion mutants in C. parapsilosis and
examined their PGE2 production. However, the PGE2 production of the OLE2 KO strain was similar to that of wild type
(WT), indicating that OLE2 is not required for prostaglandin synthesis in C. parapsilosis. Interestingly, analyses of the fatty
acid composition of WT and OLE2 KO cells by gas chromatography (GC) highlighted the accumulation of palmitoleic
and oleic acid in the OLE2 deletion mutant. The OLE2 KO cells were killed more efﬁciently by human monocytes-derived
macrophages (MDMs) as well as induced higher interleukin-10 (IL-10) secretion, indicating that OLE2 affects the
virulence of C. parapsilosis. Taken together, these results contribute to the better understanding of fatty acid
biosynthesis pathways in C. parapsilosis.
Introduction
Candida parapsilosis is an emerging opportunistic human fun-
gal pathogen, and it is currently one of the leading causes of inva-
sive candidiasis.1-3 The populations with the highest risk for
nosocomial infections with C. parapsilosis are the low-birth-
weight neonates, elderly and immunocompromised patients,
such as individuals with AIDS or organ transplantation.1,2,4
Unlike Candida albicans, C. parapsilosis is frequently transmitted
horizontally, and it can cause invasive disease without colonizing
the host before dissemination.4 The use of prosthetic devices and
indwelling catheters also increases the risk for C. parapsilosis
infection.4 However, despite its high clinical relevance, the path-
ogenesis of C. parapsilosis has remained largely obscure.
Prostaglandins (PGs) are biologically active polyunsaturated
fatty acids (PUFAs) that have important signaling and immuno-
modulatory functions.5 In mammalian cells, they are synthesized
de novo from membrane-derived arachidonic acid (AA) via cyclo-
oxigenases (COX).5,6 Prostaglandins play an important role in
the regulation of immune responses by modulating phagocytosis,
cytokine and chemokine production and release, and lymphocyte
proliferation.7 In particular, PGE2 inhibits T helper (Th) 1 and
promotes Th2 responses by modulating the cytokine production
of lymphocytes.8 Numerous pathogenic fungi, such as C. albicans
and Cryptococcus neoformans, are able to produce prostaglandins
along with other arachidonic acid metabolites.9 Importantly,
C. albicans PGE2 is biologically active on mammalian cells, as
it inhibits the proliferation of splenocytes and decreases their
TNFa production while stimulating IL-10 secretion.7 Further-
more, PGE2 modulates the morphogenesis of C. albicans, further
supporting the role of fungal prostaglandins as potential viru-
lence factors.7 Although little information is available about the
biosynthesis of prostaglandins in Candida spp., one study has
described that the multicopper oxidase gene FET3 and the
stearyl-CoA desaturase gene OLE2 are involved in PGE2 synthe-
sis in C. albicans.10 This finding indicates a direct link between
the production of fatty acids and bioactive lipid mediators,
underscoring the role of de novo fatty acid biosynthesis in patho-
genic yeasts.
Saturated and unsaturated fatty acids (SFA and UFA, respec-
tively) have an essential role in eukaryotic cells as building blocks
of membranes and lipid storage.11,12 De novo fatty acid biosyn-
thesis is essential for growth and virulence of both C. albicans
and C. parapsilosis.13-15 As in Saccharomyces cerevisiae, the
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biosynthesis of fatty acids in C. albicans and C. parapsilosis starts
with the generation of malonyl-CoA from acetyl-CoA and CO2,
via the biotin-bound enzyme acetyl-CoA carboxylase
(AccI).11,16,17 In the second step, the elongation of the carbon
chain is catalyzed by fatty acid synthases (Fas1 and Fas2) and
elongase 1 (Elo1), resulting in long-chain SFA.18,19 To produce
UFA, a subsequent desaturation reaction catalyzed by stearyl-
CoA desaturase (Ole1) is necessary to introduce a double bond
into saturated fatty acyl-CoA substrates.17,20 In C. albicans and
C. parapsilosis, there are 2 homologues with the S. cerevisiae
OLE1, OLE1 and OLE2.21 While OLE1 is essential in C. albi-
cans, deletion of OLE1 in C. parapsilosis results in UFA auxotro-
phic mutants.17,21 Importantly, Ole1 plays a crucial role in
virulence in both species, as demonstrated by in vivo murine
infection models.17,22 However, while OLE2 has been associated
with prostaglandin synthesis in C. albicans, the role of OLE2 in
C. parapsilosis is unknown.
In this study, our main objective was to examine whether C.
parapsilosis is able to synthesize prostaglandin-like molecules
from exogenous AA. Furthermore, to assess the potential role of
OLE2 in prostaglandin production, we generated an OLE2
“knock-out” (KO) C. parapsilosis strain. To gain further insights
into the role of OLE2 in the pathobiology of C. parapsilosis, we
also analyzed the fatty acid composition and the virulence prop-
erties of the mutant strain.
Results
C. parapsilosis produces prostaglandins from exogenous
arachidonic acid
First we wanted to examine whether C. parapsilosis is able to
synthesize prostaglandins from exogenous AA. To characterize
the prostaglandin profiles of C. parapsilosis and C. albicans, wild
type yeast cells were grown overnight in YPD medium and subse-
quently incubated in PBS with or without 0.5 mM AA for
24 hours. The levels of different prostaglandin derivatives
(13,14-dihydro-15-keto-PGF2a, 11b-PGF2a, PGE1, PGF1a,
PGH2, PGE2, PGF2a, PGD2, PGF2b, PGA2, PGJ2, PGB2)
in cell-free supernatants were determined by HPLC-MS analysis
(Fig. 1). Following incubation with AA, we detected a variety of
prostaglandin compounds in the supernatants of C. albicans and
C. parapsilosis cultures. In both species, the main secreted prosta-
glandins were PGD2 and PGE2. Furthermore, we also detected
compounds from other prostaglandin classes, such as PGH2,
PGF2b and PGA2, in the supernatants of both C. albicans and
C. parapsilosis cultures. However, we did not detect any prosta-
glandin production in our experimental system when Candida
cells were incubated solely in PBS. These results clearly demon-
strate that, C. parapsilosis synthesizes prostaglandins from exoge-
nous AA.
CpOLE2 is not required for prostaglandin synthesis
The biosynthetic pathway of fungal eicosanoid production is
still not fully understood. However, several candidate enzymes,
including cytochrome P450s and multicopper oxidases have been
implicated in prostaglandin production.23 The disruption of the
putative D9-desaturase gene OLE2 in C. albicans results in signif-
icantly decreased PGE2 production.10 Therefore, in order to
examine whether OLE2 is involved in prostaglandin synthesis in
C. parapsilosis, we constructed homozygous OLE2 deletion
mutants (Fig. S1), and tested their PGE2 production using
HPLC-MS as well as a monoclonal PGE2 EIA kit. However, we
found that OLE2 mutants secreted PGE2 in amounts that were
similar to that of the WT parental strain (Fig. 2). Therefore,
OLE2 is not required for PGE2 biosynthesis in C. parapsilosis.
Role of CpOLE2 in de novo fatty acid biosynthesis
After the finding that OLE2 is not required for PGE2 produc-
tion in C. parapsilosis, we asked the question whether it has a role
in de novo fatty acid biosynthesis. To investigate this possibility,
we compared the fatty acid profile of OLE2 mutants with that of
WT C. parapsilosis. The amount of different fatty acids (palmitic
acid, palmitoleic acid, palmitolinoleic acid, stearic acid, oleic
acid, linoleic acid and linolenic acid) in fungal cell extracts was
determined by gas chromatography. Figure 3 shows the fatty
acid composition of OLE2 KO C. parapsilosis cells relative to that
of WT cells. Interestingly, we found that OLE2 mutants accumu-
lated significantly more palmitoleic and oleic acid compared to
WT C. parapsilosis cells (mean § SEM, palmitoleic acid,
615.0 § 117.5 vs. 228.1 § 29.1 ng/mg dry weight, P < 0.05;
oleic acid, 16.3 § 0.5 vs. 9.2 § 0.9 mg/mg dry weight, P <
0.01). These monounsaturated fatty acids are synthesized from
palmitic and stearic acid, respectively, via D9-desaturases, and are
further converted into palmitolinoleic (16:2 n-4) and linoleic
acid (18:2) by D12-desaturases. However, we found that the cel-
lular levels of palmitic and stearic acids as well as that of palmito-
linoleic and linoleic acids were unaffected by the absence of
OLE2. Taken together, these results suggest that C. parapsilosis
Ole2 is involved in fatty acid biosynthesis and the action is pre-
sumably not or not exclusively a D9-desaturase.
OLE2 C. parapsilosismutants have decreased virulence
in vitro
Next we sought to determine whether the lack of OLE2
affected the virulence of C. parapsilosis. First we examined the
growth of OLE2 mutants in comparison to WT on different
media (YPD, YNB, YCB/BSA; Fig. S1), at different temperatures
(20C, 30C, 37C; Fig. S2), as well as at different pH ranges
(pH 4-8; Fig. S3). We also assessed the growth of the mutant
strain under different oxidative, membrane and cell wall stress-
inducing conditions (H2O2, SDS, calcofluor white, congo red,
caffeine; Fig. S4). However, the growth of the mutant strain was
similar to the WT for all circumstances tested. Also, OLE2 dele-
tion did not affect the formation of pseudohyphae (Fig. S5).
Next we investigated the phagocytosis and killing of OLE2
mutants by primary human monocyte-derived macrophages
(MDMs) using an acridin orange staining method (Fig. 4). We
found that more MDMs phagocytosed the OLE2 mutants (phag-
ocytosis%, mean § SEM, 69.2 § 5.7% vs. 52.7 § 4.9%, P <
0.05, Fig. 4C), and OLE2 deficient cells were killed with signifi-
cantly higher efficiency compared to WT yeasts (killing
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efficiency, mean § SEM, 50.2 § 8.7% vs.
41.2 § 8.4%, P < 0.05, Fig. 4D). We also
examined the killing of OLE2 mutant C.
parapsilosis cells by CFU determinations,
which confirmed the results of the fluores-
cence microscopic analysis (Fig. 4E). As
fungal lipids can modulate the immune
response,7 we also examined the cytokine
secretion of MDMs following stimulation
with OLE2 mutants or WT C. parapsilosis
cells. We found that while the level of
TNFa, IL-1b and IL-6 were similar in
MDMs stimulated with OLE2 mutant or
WT C. parapsilosis (not shown), OLE2
mutants stimulated significantly higher IL-
10 production than WT cells (mean §
SEM, 581.8 § 292.2 pg/mL vs. 437.0 §
246.9 pg/mL, P < 0.05, n D 5). Fig. 4F
shows the cytokine secretion of MDMs
stimulated with OLE2 KO or WT C. para-
psilosis (cytokine levels were normalized for
each donor to cytokine levels induced by
WT cells [100%] to exclude donor-to-donor
variability). Altogether, these results suggest
that OLE2 affects the virulence of C. para-
psilosis, although further research is war-
ranted to determine its specific role during
infection.
Discussion
Several pathogenic Candida spp., includ-
ing C. albicans, C. tropicalis and C. dublin-
iensis produce prostaglandins.7,24 In this
report, we demonstrate that C. parapsilosis is
also capable of synthesizing prostaglandins
from exogenously added AA. We show that
the prostaglandin profile of C. parapsilosis is
similar to that of C. albicans, with PGE2 and
PGD2 being the main prostaglandins pro-
duced. In mammals, prostaglandins are
important signaling molecules that are cru-
cial for the regulation of the inflammatory
response.5 They are synthesized from AA
which is liberated from membrane phospho-
lipids by phospholipase A2 upon inflamma-
tory stimuli.8 Subsequently, AA is converted
to PGH2 by cyclooxigenases, and PGH2 is
further processed by tissue-specific prosta-
glandin synthases to give rise to a series of
different classes of prostaglandins.8 Secre-
tion of fungal prostaglandins during infec-
tion may substantially influence the host’s
immune response, promoting the survival of
the pathogen. Notably, we found that the
Figure 1. C. albicans and C. parapsilosis produce prostaglandins from exogenous AA. C. albicans
and C. parapsilosisWT strains were cultured in YPD medium overnight, washed, and subsequently
incubated in PBS for 24 h with 500 mM AA. The concentration of different prostaglandin com-
pounds in culture supernatants was determined by HPLC-MS analysis. Results are representative
of 2 independent experiments.
Figure 2. CpOLE2 is not required for PGE2 synthesis. C. parapsilosis WT and OLE2 KO strains were
cultured in YPD medium overnight, washed, and subsequently incubated in PBS for 24 h with or
without 500 mM AA.The concentration of PGE2 in culture supernatants was determined by HPLC-
MS (A) or EIA (B). Results are mean § SEM and represent the average of 3 independent
experiments.
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most abundant prostaglandin produced by both C. albicans and
C. parapsilosis was PGD2, which exerts both pro-and anti-inflam-
matory properties, and is also involved in thermoregulation, hor-
mone release and pain responses in mammals. Furthermore,
PGD2 is converted by a non-enzymatic reaction to 15-deoxy-
D12,14-PGJ2, which is a potent anti-inflammatory lipid media-
tor and has been shown to inhibit the NFkB signaling pathway.25
As a potent pro-inflammatory response is required for the suc-
cessful clearance of invasive Candida, the anti-inflammatory
effects of 15-deoxy-D12,14-PGJ2 may be beneficial for the path-
ogen. PGE2 was also produced in high concentrations by C. albi-
cans and C. parapsilosis, and PGE2 mediates T-cell responses and
influences other physiological functions.8 Due to its ability to
block Th1-type responses and promote Th2-type immunity,8
fungal PGE2 may also help the pathogen survive in the host.
Although the pathway of eicosanoid production in mamma-
lian cells is well studied, little is known about the biosynthesis of
prostaglandins in lower eukaryotes. While C. albicans does not
possess cyclooxigenases, several enzymes, such as the fatty acid
desaturase Ole2 and the multicopper oxidase Fet3 have been
shown to contribute to prostaglandin production.10 The presence
of a conserved D9-desaturase domain in Ole2 protein suggested
that it has D9-desaturase activity, while its cytochrome B domain
was thought to be responsible for prostaglandin synthesis.10
However, the role of OLE2 in C. parapsilosis has never been pre-
viously investigated. To examine whether OLE2 is involved in
prostaglandin synthesis in C. parapsilosis, we generated OLE2
deletion mutants using a previously described gene disruption
technique.26 However, we found that there was no difference
between the PGE2 secretion of WT and OLE2 KO C. parapsilosis
cells. The fact that OLE2 is not required for PG synthesis in C.
parapsilosis is unexpected, but can be explained considering that
C. albicans and C. parapsilosis have crucial differences in their
fatty acid metabolism. Interestingly, we also found that OLE2
mutants had a different fatty acid composition compared to WT
cells, containing higher amounts of palmitoleic and oleic acids.
These UFAs are produced from palmitic and stearic acids, respec-
tively, by D9-desaturases and are further converted to PUFAs via
D12-desaturases.27 The accumulation of palmitoleic and oleic
acids in OLE2 KO cells argues against the role of OLE2 as an
exclusive D9-desaturase and suggests that it may have other enzy-
matic activities as well. These results are in line with the findings
of Krishnamurthy et al., who demonstrated that heterologous
expression of CaOLE2 could not reconstitute the phenotype of S.
cerevisiae OLE1 (D9-desaturase) mutants, implicating that Ole2
is not a D9-desaturase.21 Moreover, UFA auxotrophic OLE1 C.
parapsilosis mutants are unable to grow in SFA-supplemented
media without the presence of UFA, indicating that Ole1 is the
only enzyme in C. parapsilosis responsible for the synthesis of
these essential fatty acids.17 Further supporting these results, we
found that Ole2 proteins from different Candida species (includ-
ing C. parapsilosis and C. albicans) form a phylogenetically dis-
tinct group which is far from both D9¡ and D12¡ fungal
desaturases (Fig. S6).
Interestingly, we also found that OLE2 KO C. parapsilosis cells
were phagocytosed and killed more efficiently by human macro-
phages compared to WT cells. One potential explanation for this
decreased virulence is that the accumulated UFAs are toxic to
yeast cells; however, we found no difference between the growth
of OLE2 KO and WT strains in medium conditions, making
this possibility unlikely. On the other hand, as it has been shown
with OLE1 KO C. parapsilosis cells,17 OLE2 mutants could
become hypersensitive to cellular stress. However, we found that
the lack of OLE2 did not impact the capacity of C. parapsilosis to
cope with extracellular stressors such as H2O2 or SDS (data not
shown). In addition to increased phagocytosis and killing, OLE2
mutants also stimulated higher IL-10 production in macrophages
compared to WT cells. IL-10 has been shown to increase the
phagocytic capacity of macrophages28; therefore, suppression of
IL-10 secretion may also be beneficial for the pathogen during
infection.
There is an increasing amount of evidence showing that the
integrity of fatty acid biosynthesis pathways in pathogenic fungi
is essential for growth and virulence. For example, the downregu-
lation of fatty acid synthase genes FAS1 and FAS2 substantially
affects the virulence of C. neoformans in a murine model of pul-
monary cryptococcosis.29 Similarly, fatty acid synthase 2 (FAS2)
mutant C. parapsilosis cells are defective in biofilm formation, are
highly sensitive to human serum and have decreased virulence in
vivo compared to WT cells.30 Moreover, the stearyl-CoA desatur-
ase Ole1 regulates the stress response and cellular morphology of
C. albicans and C. parapsilosis, and it plays a major role in the
Figure 3. OLE2 KO C. parapsilosis cells have altered fatty acid composi-
tion. WT and OLE2 KO C. parapsilosis cells were cultured in YPD medium
overnight, washed, lyophilized, and subjected to analysis by gas chroma-
tography. For better comparison, fatty acid levels were normalized to
those of WT cells and expressed as %. The actual concentration of palmi-
toleic and oleic acid (expressed as ng/mg or mg/mg dry weight) is
described in Results. Data are mean § SEM and represent the average
of 3 independent experiments. *P < 0.05, **P < 0.01 by unpaired t-test.
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pathobiology of both species.17,22 In accordance with these find-
ings, our results further support the role of fatty acid homeostasis
in the virulence of pathogenic fungi.
Taken together, we have shown here that C. parapsilosis is
capable of producing prostaglandins similarly to other Candida
spp. Furthermore, we generated a OLE2 KO C. parapsilosis strain
to assess the role of this gene in prostaglandin synthesis. Although
we found that OLE2 is not required for PGE2 synthesis in C. par-
apsilosis, we show that OLE2 deficient C. parapsilosis cells have
altered fatty acid composition, which is accompanied by
decreased virulence in vitro. Although further investigation is
needed to reveal the exact function of OLE2 during infection,
our results contribute to the better understanding of fatty acid
biosynthesis pathways in Candida parapsilosis.
Materials and Methods
Strains and growth conditions
Unless otherwise specified, C. albicans SC5314, Candida par-
apsilosis strains (GA1 wild type [WT]31 and OLE2 mutant
[DCpole2/DCpole2::FRT]) were grown overnight in liquid YPD
medium (1% yeast extract, 2% bactopepton, 2% glucose) at
30C. Cells were harvested by centrifugation, washed twice with
PBS (phosphate-buffered saline; 137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 2 mM KH2PO4; pH 7.4) and counted in a
B€urker-chamber prior to experiments.
Generation of the disruption constructs pSFS2Ole2 and
pSFS2NewOle2
The pSFS2Ole2 and pSFS2NewOle2 plasmids were used to dis-
rupt the open reading frame of the OLE2 gene, consisting of 1
653 nucleotides. In order to construct the pSFS2Ole2 vector, a
599bp upstream and a 594bp downstream fragment was amplified
from C. parapsilosis GA1 genomic DNA. For the amplification of
the upstream PCR product “CpOLE2 upstKpnIfrw” (50-
ttttttggtaccGAAAAATGAAGCTAAATCCTCCAAGGGAC-30;
[KpnI site underlined]) and “CpOLE2 upstXhoI rev” (50-
ttttttctcgagATAGGAAAAGTAGTTGAAAATGCGCACAC-30;
[XhoI]) primers were used. For the amplification of the down-
stream PCR product “CpOLE2 down NotIfrw” (50-
ttttttgcggccgcGCGTTGTTTCTCATCCATTTGAGGAAATTC-
30; [NotI]) and “CpOLE2 down SacI rev” (50-ttttttgagctcGGTT-
TATACTCAAATGGATGAATAGTCTTCTG-30; [SacI]) primers
were used. To construct the pSFS2NewOle2 vector, only the
upstream region was changed for easier detection of the elimination
Figure 4. The lack of OLE2 affects the virulence of C. parapsilosis. (A–B)
Acridine orange staining of MDMs co-cultured for 3 h with WT (A) or
OLE2 KO (B) C. parapsilosi s. Live cells show green ﬂuorescence (green
arrow), dead cells show red ﬂuorescence (red arrow). (C) Phagocytosis of
WT and OLE2 KO C. parapsilosis by human MDMs as determined by ﬂuo-
rescent microscopic analysis. Phagocytosis is expressed as the percent of
macrophages that have ingested at least one yeast cell (phagocytosis%).
Data represent mean § SEM for 4 donors. (D) Intracellular killing of WT
and OLE2 KO C. parapsilosis by human MDMs as determined by ﬂuores-
cent microscopic analysis. Results represent the percent of dead yeast
cells § SEM for 4 donors. AO, acridin orange. (E) Killing of WT and OLE2
KO C. parapsilosis by human MDMsas measured by CFU determinations.
Data were normalized to WT and represent mean § SEM for 4 donors.
(F) MDMs were stimulated for 24 h with WT or OLE2 KO C. parapsilosis
and the concentration of IL-10 in cell culture supernatants was deter-
mined by ELISA. Data were normalized for each donor to cytokine levels
induced by the WT strain (100%) and are expressed as mean § SEM for
5 donors. Actual cytokine levels are described in Results. *P < 0.05 as
determined by paired t-test using the GraphPad Prism 5 software.
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of the second allele. For the amplification of the upstream 417 bp
PCR product “CpOLE2 NewupstKpnIfrw” (50-ttttttggtaccC-
TATTTACACTAAGCAGCTTCGGCAG-30; [KpnI]) and
“CpOLE2 NewupstXhoI rev” (50-ttttttctcgagGGCACACCAA-
TATCTAAACTACCATTG-30; [XhoI]) primers were used. The
PCR fragments were ligated into pSFS232 appropriate cloning sites
(KpnI/XhoI and NotI/SacI) to generate the pSFS2Ole2 and
pSFS2NewOle2 disruption plasmids.
Candida parapsilosis transformation and generation
of CpOle2 deletion mutants
C. parapsilosis WT cells were transformed by electroporation
as previously described,31 with 5 mg KpnI-SacI digested and
purified fragment from the pSFS2Ole2 plasmid. For the disrup-
tion of the second allele, heterozygous mutants (OLE2/D ole2 ::
FRT) were transformed with 5 mg KpnI-SacI digested and puri-
fied fragment from the pSFS2NewOle2 plasmid. Transformants
were regenerated and analyzed by Southern blotting
(Fig. Supplementary 1). As our primary focus was to measure
the production of prostaglandins and we did not find any differ-
ence between the WT and OLE2 strain, we did not include the
reconstituted strain in our study.
Determination of prostaglandin profile by HPLC-MS
For prostaglandin measurements, 100 ml PBS (control) or
100 ml PBSCAA (500 mM AA [Sigma, A9673] in PBS) was
inoculated with 2 £ 109 yeast cells and incubated for 24 h at
30C. Subsequently, cells were harvested by centrifugation and
the supernatants were collected by sterile filtration. Samples were
analyzed with HPLC-MS technique using an Agilent 1100 liquid
chromatograph and an Agilent 6410 triple quadrupole mass
spectrometer (Palo Alto, USA). For the HPLC separation, a
YMC Pack ProC18 (150 mm £ 2.1 mm, 5 mm) (Dinslaken,
Germany) column was applied with a guard column (20 mm £
2.1 mm, 5 mm). The A eluent was water, while the B eluent was
acetonitrile/methanol (95:5) and both of them were supple-
mented with 0.005% acetic acid. The flow rate of the mobile
phase was 0.3 ml/min with the gradient program progressing
from 25% to 40% at 10 minutes and 50% at 20 minutes, and
then reduced to 25% for an additional 15 minutes. For ioniza-
tion, an ESI ion source was used with negative ionization at the
following mass spectrometric parameters: nitrogen drying gas
temperature, 325C; drying gas flow, 12 l/min; capillary voltage,
3800 V; fragmentation voltage, 110 V. The analyzer operated in
the multiple reaction monitoring (MRM) mode using
2 transitions for each components with the following transition
and collosion energy (CE) parameters: 13,14-dihydro-15-keto-
prostaglandin F2a (DKPGF2a, 353.2!309.1-20V, 291.2-
20V), 11b-Prostaglandin F2a (11bPGF2a, 353.2!309.1-20V,
291.2-20V), Prostaglandin E1 (PGE1, 353.2!309.1-20V,
273.3-20V), Prostaglandin F1a (PGF1a, 355.5!311.2-20V,
293.2-20V), Prostaglandin H2 (PGH2, 351.3!271.2-15V,
180.1-15V), Prostaglandin E2 (PGE2, 351.3!271.2-15V,
315.1-15V), Prostaglandin F2a (PGF2a, 353.2!317.2-20V,
273.3-20V), Prostaglandin D2 (PGD2, 351.3!271.2-15V,
189.1-15V), Prostaglandin F2b (PGF2b, 353.2!291.2-20V,
317.2-20V), Prostaglandin A2 (PGA2, 333.3!271.2-20V,
189.2-20V), Prostaglandin J2 (PGJ2, 333.3!271.2-20V,
189.2-20V), Prostaglandin B2 (PGB2, 333.3!235.0-20V,
175.0-20V). For method development and quantifications, the
Prostaglandin HPLC mixture (10002), Cyclopentenone Prosta-
glandin HPLC mixture (10000), Prostaglandin Metabolite
HPLC mixture (10005) and Prostaglandin H2 (17020, all from
Cayman Chemical) were used. All measurements were carried
out in triplicates.
Determination of fatty acid composition of C. parapsilosis
strains by gas chromatography
For fatty acid measurements, strains were grown as described
in 1 l YPD medium. After washing with PBS, yeast cells were
lyophilized. The sample preparation was carried out according to
Wei et al.33 with minor modifications. Approximately 100 mg
of a lyophilized sample was supplemented with 100 mg heptade-
canoic acid (Sigma, H3500) as internal standard (1000 mg/ml).
Samples were suspended in 5 ml of 5% methanolic solution of
potassium hydroxide and saponified at 70C for 1 hour. Subse-
quently, the pH of the mixture was adjusted to 2 with HCl. A
mixture of 4 ml water and 2 ml chloroform was added and the
samples were vigorously shaken. The chloroform phase was col-
lected after centrifugation (4000 rpm, 4C, 15 min) and the
extraction was repeated again from the upper phase with 1 ml
chloroform. The collected chloroform phases were pooled and
evaporated under a stream of nitrogen. Four ml of 14% metha-
nolic solution of boron-trifluoride was added to the saponified
samples, and incubated at 70C for 1.5 hour. The fatty acid
methyl-esters (FAMEs) were partitioned with hexane, which was
evaporated to dryness under nitrogen. Finally, the derivatized
samples were reconstituted in 50 ml hexane before chro-
matographic analysis. The samples were analyzed with an Agilent
6890N (Palo Alto, USA) gas chromatograph (GC) and fatty acid
methyl esters were identified by comparison of their retention
times with those of standards (methyl palmitate, Sigma, P5177;
methyl palmitoleate, Sigma, P9667; 9(Z),12(Z)-hexadecadie-
nioc-acid methyl ester, Larodan AB, 20-1620-4; methyl stearate,
Sigma, S5376; methyl oleate, Sigma, 311111; methyl linoleate,
Sigma, L1876; methyl linolenate, Sigma, L2626). The instru-
ment was equipped with an FID detector and an HP-Innowax
(60 m*0.25 mm*0.5 mm) (Hewlett-Packard, USA) column.
The injected volume was 1 ml of sample in split mode (split ratio
was 50:1) and the injector and detector temperatures were
250C. The temperature gradient was 50C for 2 min, then
increased to 200C by 20C/min, and then followed by increases
of 3C/min to reach 240C where it was maintained for 50 min.
For the separations, constant pressure mode (32 psi) was used
and the flow of the detector gases were 30 ml/min, 300 ml/min
and 20 ml/min for the hydrogen, air and nitrogen, respectively.
The samples were analyzed under the same conditions at least
3 times.
Isolation of human peripheral blood mononuclear cells
(PBMCs) and differentiation of monocyte-derived macrophages
(MDM) (under approval of the institutional ethical review board
of Szeged University)
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PBMC isolation and differentiation was carried out as
described34 with minor modifications. Following isolation,
PBMCs were plated on different cell culture plates: 96-well for
killing assay (5 £ 105cell/well); tissue culture coverslips (13mm,
SARSTEDT, 83.1840.002) for acridine orange staining (5 £
105cell/coverslip) or 12-well for cytokine measurement (107cell/
well). To differentiate macrophages, isolated monocytes were cul-
tured for 7 d in X-VIVO 15 medium (Lonza, 04-744Q)
supplemented with 10 ng/mL recombinant human granulocyte-
macrophage colony-stimulating factor (GM-CSF, Sigma-
Aldrich, SRP3050) and 1% 100_c penicillin–streptomycin
solution (Sigma-Aldrich, P0781).
Fluorescent microscopy
MDMs were cultured on tissue culture coverslips (13 mm,
SARSTEDT) in 12-well cell culture plates. The in vitro infection
of the macrophages was carried out at a 1:5 macrophage:yeast
ratio. After 3 h incubation at 37C, the samples were stained
with 0.01% acridine orange dye (Sigma, 235474) as described.34
This method allows differentiation between live and dead yeast
cells. When acridine orange binds to intact (ds) DNA, it emits
green fluorescence, while binding to damaged (ss) DNA it shows
red fluorescence, indicating dead cells. For quenching the fluores-
cence of non-phagocytosed yeast cells, 0.05% crystal violet
(Sigma, C3886) dye was used. The killing efficiency was calcu-
lated as follows: (number of dead yeast cells / number of engulfed
yeast cells) £ 100. Phagocytosis% was calculated as follows:
(phagocytosing macrophages / all macrophages) £ 100. In every
experiment, 10 fields in each well were counted, and approxi-
mately 1000 MDMs were analyzed in each well.
Killing assay
Human macrophages were cultured on 96-well tissue culture
plates. The in vitro infection of the macrophages was carried out
at a 1:5 macrophage:yeast ratio. As a control, the same number
of yeast cells were incubated in cell culture medium without mac-
rophages. The killing assays were carried out as described.34
Cytokine measurements
Human macrophages were cultured on 12-well tissue culture
plates. The in vitro infection of the macrophages was carried out
at a 1:5 macrophage:yeast ratio. Cell culture supernatants were
collected after 24 h and stored at ¡20C until assayed for cyto-
kine production. The concentration of cytokines in cell culture
supernatants was determined by DuoSet ELISA Kits (R&D Sys-
tems; TNFa, DY210; IL-1b, DY201; IL-6, DY206; IL-10,
DY217B) according to the manufacturer’s instructions.
PGE2 EIA
For PGE2 measurement, the strains were grown as described
above. Subsequently, 100 ml PBS (control) or 100 ml PBS C
AA (500 mM AA [Sigma] in PBS) was inoculated with 2 £ 109
yeast cells and incubated for 24 h at 30C. Cells were harvested
by centrifugation and the supernatants were sterile filtered. Sam-
ples were purified on a PGE2 Affinity Column (Cayman Chemi-
cal, 400056) and analyzed with a Prostaglandin E2 EIA Kit –
Monoclonal (Cayman Chemical, 514010) according to the man-
ufacturer’s instructions.
Statistical analysis
GraphPad Prism 5 software was used for statistical analysis.
Data were analyzed by paired or unpaired t-test (see Figure
legends for details) and differences were considered statistically
significant at P < 0.05. All experiments were performed at least
twice (see Results and figure legends for details).
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